Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a ...
Q1 2026
May 15, 2026
FY 2025
Mar 12, 2026
Q4 2025
Q3 2025
Oct 30, 2025
Q2 2025
Aug 14, 2025